The over-activation of AKT, caused by the increased synthesis of the membrane lipid PIP3 (phosphatidyl-inositol-3,4,5-tris-phosphate), produced by PI3K, has been described in 50% of human cancers [14,15,16,17]. The gene discussed is AKT1; the disease is cancer.